These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23340734)

  • 21. MC1R germline variants confer risk for BRAF-mutant melanoma.
    Landi MT; Bauer J; Pfeiffer RM; Elder DE; Hulley B; Minghetti P; Calista D; Kanetsky PA; Pinkel D; Bastian BC
    Science; 2006 Jul; 313(5786):521-2. PubMed ID: 16809487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular testing in malignant melanoma.
    Grossmann AH; Grossmann KF; Wallander ML
    Diagn Cytopathol; 2012 Jun; 40(6):503-10. PubMed ID: 22619125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions.
    Maldi E; Travelli C; Caldarelli A; Agazzone N; Cintura S; Galli U; Scatolini M; Ostano P; Miglino B; Chiorino G; Boldorini R; Genazzani AA
    Pigment Cell Melanoma Res; 2013 Jan; 26(1):144-6. PubMed ID: 23051650
    [No Abstract]   [Full Text] [Related]  

  • 24. Melanomas of unknown primary have a mutation profile consistent with cutaneous sun-exposed melanoma.
    Dutton-Regester K; Kakavand H; Aoude LG; Stark MS; Gartside MG; Johansson P; O'Connor L; Lanagan C; Tembe V; Pupo GM; Haydu LE; Schmidt CW; Mann GJ; Thompson JF; Scolyer RA; Hayward NK
    Pigment Cell Melanoma Res; 2013 Nov; 26(6):852-60. PubMed ID: 23890154
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melanoma researchers have a reason to GRIN: melanoma yields more of its secrets to exome sequencing.
    Meltzer P
    Pigment Cell Melanoma Res; 2011 Aug; 24(4):590-1. PubMed ID: 21592317
    [No Abstract]   [Full Text] [Related]  

  • 26. Germline BAX deletion in a patient with melanoma and gastrointestinal stromal tumor.
    Silva AG; Lisboa BC; Achatz MI; Carraro DM; da Cunha IW; Pearson PL; Krepischi AC; Rosenberg C
    Am J Gastroenterol; 2013 Aug; 108(8):1372-5. PubMed ID: 23912413
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
    Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
    Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth control by tumor suppressors in malignant melanoma.
    Coleman A; Robertson G; Lugo TG
    Receptor; 1995; 5(1):9-19. PubMed ID: 7613487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recurrent somatic activating RAC1 mutations in melanoma].
    Dereure O
    Ann Dermatol Venereol; 2012 Nov; 139(11):785-6. PubMed ID: 23199784
    [No Abstract]   [Full Text] [Related]  

  • 30. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [After diagnosing melanoma in a patient: evaluation of risks of second melanoma and melanoma in the family].
    Cesarini JP; Beltzer-Garelly E; Binet O
    Ann Dermatol Venereol; 1995; 122(5):305-9. PubMed ID: 8572471
    [No Abstract]   [Full Text] [Related]  

  • 32. Tracing Melanoma's Genetic Progression.
    Cancer Discov; 2016 Feb; 6(2):114. PubMed ID: 26681739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cutaneous malignant melanoma: one single disease ?].
    Piérard GE; Piérard-Franchimont C; Hermanns-Lê T; Delvenne P
    Rev Med Liege; 2012 Sep; 67(9):458-60. PubMed ID: 23115846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Driver KIT mutations in melanoma cluster in four hotspots.
    Dumaz N; André J; Sadoux A; Laugier F; Podgorniak MP; Mourah S; Lebbé C
    Melanoma Res; 2015 Feb; 25(1):88-90. PubMed ID: 25304235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of a novel Chinese metastatic melanoma cell line showing the new cytogenetic and biological properties.
    Yi X; Zhu G; Li Y; Liu Y; Luan Q; Dai W; Wang L; Liao W; Gao T; Li C
    Cell Biol Int; 2015 Apr; 39(4):508-14. PubMed ID: 25639772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Insights into melanoma from a pathologist's perspective].
    Mihic-Probst D; Beer M
    Praxis (Bern 1994); 2013 Feb; 102(4):219-24. PubMed ID: 23399605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling epidermal melanoma in mice: moving into new realms but with unexpected complexities.
    Handoko HY; Box NF; Walker GJ
    J Invest Dermatol; 2012 Sep; 132(9):2299-302. PubMed ID: 22696058
    [No Abstract]   [Full Text] [Related]  

  • 38. Growth factors rescue cutaneous melanoma cells from apoptosis induced by knockdown of mutated (V 600 E) B-RAF.
    Christensen C; Guldberg P
    Oncogene; 2005 Sep; 24(41):6292-302. PubMed ID: 16007203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathology of skin neoplasms of the head and neck.
    Kraft S; Granter SR
    Arch Pathol Lab Med; 2014 Jun; 138(6):759-87. PubMed ID: 24878016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TERT promoter mutation is uncommon in acral lentiginous melanoma.
    Liau JY; Tsai JH; Jeng YM; Chu CY; Kuo KT; Liang CW
    J Cutan Pathol; 2014 Jun; 41(6):504-8. PubMed ID: 24588324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.